Articles

1. In silico and network pharmacology analysis of fucosterol: a potent anticancer bioactive compound against HCC

   • Kajal Singh
   • Pradeep Kumar
   • Sunil Kumar Mishra

   Original Paper 27 April 2024 Article: 130

   

2. Retraction Note: Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway

   • Shengyou Ge
   • Kexin Wang
   • Lin Wang

   Retraction Note 26 April 2024 Article: 129

3. Role of the STING pathway in myeloid neoplasms: a prospero-registered systematic review of principal hurdles of STING on the road to the clinical practice

   • Leticia Rodrigues Sampaio
   • Ricardo Dyllan Barbosa Dias
   • Ronald Feitosa Pinheiro

   Review Article 24 April 2024 Article: 128

   

4. A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases

   • Salim Hussein Hassan
   • Mohammad Y. Alshahrani
   • Ahmed Elawady

   Review Article 24 April 2024 Article: 127

   

5. Challenges and strategies in relation to effective CAR-T cell immunotherapy for solid tumors

   • Guangxun Yuan
   • Mengke Ye
   • Xun Zeng

   Review Article 23 April 2024 Article: 126

   

6. Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives

   • Alborz Soroush
   • Siavash Pourhossein
   • Sepideh Karkon Shayan

   Review Article 23 April 2024 Article: 125

   

7. Ferroptosis is an effective strategy for cancer therapy

   • Afrasyab Khan
   • Yu Huo
   • Yongzhong Hou

   Review Article 23 April 2024 Article: 124

   

8. N-methyl-D-aspartate receptors and thymoquinone induce apoptosis and alteration in mitochondria in colorectal cancer cells

   • Ferhat Sirinyildiz
   • Simge Unay

   Original Paper 23 April 2024 Article: 123

   

9. Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy

   • Abdur Rauf
   • Payal B. Joshi
   • Rekha Thiruvengadam

   Review Article 23 April 2024 Article: 122

   

10. Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression

    • Afrah Fatthi Salama
    • Ali H. El-Far
    • Alaa Elmetwalli

    Correction Open access 22 April 2024 Article: 121

11. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner

    • Zhe Yin
    • Xiong Guo
    • Ziwei Wang

    Original Paper 20 April 2024 Article: 120

    

12. The role of SWI/SNF complexes in digestive system neoplasms

    • Hanyun Liang
    • Xin Zheng
    • Jie Zheng

    Review Article 17 April 2024 Article: 119

    

13. Identification of small molecule inhibitors against Lin28/let-7 to suppress tumor progression and its alleviation role in LIN28-dependent glucose metabolism

    • Rachanaa Raja
    • Rajamanikandan Sundararaj
    • Ruckmani Kandasamy

    Original Paper 17 April 2024 Article: 118

    

14. Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach

    • Ahad Amer Alsaiari
    • Amal F. Gharib
    • Mohammed Ageeli Hakami

    Original Paper 17 April 2024 Article: 117

    

15. Liver cancer wars: plant-derived polyphenols strike back

    • Chengu Niu
    • Jing Zhang
    • Patrick I. Okolo 3rd

    Review Article 16 April 2024 Article: 116

    

16. Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma

    • Sohini Roy
    • Geetha Shanmugam
    • Koustav Sarkar

    Original Paper 15 April 2024 Article: 115

    

17. Dual function of activated PPARγ by ligands on tumor growth and immunotherapy

    • Mingjun Chen
    • Huijie Wang
    • Yongzhong Hou

    Review Article 15 April 2024 Article: 114

    

18. A novel α,β-unsaturated ketone inhibits leukemia cell growth as PARP1 inhibitor

    • Weijia Zhao
    • Min Mo
    • Baofei Sun

    Original Paper 11 April 2024 Article: 113

    

19. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies

    • Khubaib Ali
    • Muhammad Nabeel
    • Hamid Saeed

    Review Article 09 April 2024 Article: 112

    

20. Coadministration of doxorubicin with vitamin D3, Lactobacillus acidophilus, and Lactobacillus casei in the 4T1 mouse model of breast cancer: anticancer and enteroprotective effects

    • Mohammad Ali Mirzadeh
    • Majid Eslami
    • Abbas Pakdel

    Original Paper 09 April 2024 Article: 111

    

21. Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer

    • Shahnaz Hosseinzadeh
    • Mahsa Imani
    • Elham Safarzadeh

    Original Paper 09 April 2024 Article: 110

    

22. Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line

    • Nazli Demirkiran
    • Bengusu Aydin
    • H. Ogun Sercan

    Original Paper 09 April 2024 Article: 109

    

23. Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights

    • Ahmadreza Lagzian
    • Marziye Askari
    • Yalda Malekzadegan

    Review Aritcle 09 April 2024 Article: 108

    

24. Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation

    • Nawaneetan Sriraman
    • Ankita Sarkar
    • Koustav Sarkar

    Original Paper 05 April 2024 Article: 107

    

25. Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment

    • Alaa Elmetwalli
    • Mohamed O. Abdel-Monem
    • Mervat G. Hassan

    Original Paper Open access 04 April 2024 Article: 106

    

26. Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells

    • Mohammed Salama
    • Abeer Ali
    • Seham Elabd

    Original Paper Open access 04 April 2024 Article: 105

    

27. Unlocking the potential: phenylboronic acid as a nuclear-targeting boron agent for neutron capture therapy

    • Jiejian Chen
    • Yonghao Li
    • Guolong Liu

    Original Paper 04 April 2024 Article: 104

    

28. Regulation of hippo signaling mediated apoptosis by Rauvolfia tetraphylla in triple-negative breast cancer

    • B. Balavaishnavi
    • M. Kamaraj
    • Mohammed Rafi Shaik

    Original Paper 29 March 2024 Article: 103

    

29. Investigating the correlation between prominent viruses and hematological malignancies: a literature review

    • Arian Haghtalab
    • Milad Hejazi
    • Ataollah GhalibafSabbaghi

    Review Article 28 March 2024 Article: 102

30. Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer

    • Abdulkarim S. Binshaya
    • Omar Saad Alkahtani
    • Hassan H. Almasoudi

    Original Paper 28 March 2024 Article: 101

    

31. YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt/β-catenin signaling axis

    • Yuanben Wang
    • Yulin Cao
    • Zhaohui Huang

    Original Paper 27 March 2024 Article: 100

    

32. Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer

    • Anne-Dorthe Mosgaard Knudsen
    • Mikala Wej Modvig
    • Annette Raskov Kodahl

    Original Paper Open access 27 March 2024 Article: 99

    

33. Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review

    • Sandipan Dasgupta
    • Sakuntala Gayen
    • Souvik Roy

    Review Article 27 March 2024 Article: 98

    

34. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach

    • Bahar Kartal
    • Farika Nur Denizler-Ebiri
    • Mehmet Taşpınar

    Original Paper Open access 26 March 2024 Article: 97

    

35. Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment

    • XiangFei Zhao
    • RuGang Zhao
    • Yi Hu

    Original Paper 25 March 2024 Article: 96

    

36. Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulation

    • Mainuddin
    • Anoop Kumar
    • Amulya Jindal

    Original Paper 25 March 2024 Article: 95

    

37. Regulation of cancer progression by CK2: an emerging therapeutic target

    • Shakeel Hussain
    • Yilei Guo
    • Yongzhong Hou

    Review Article 25 March 2024 Article: 94

    

38. Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing

    • Kai Xiong
    • Yuqi Fang
    • Bo Zhu

    Original Paper 25 March 2024 Article: 93

    

39. Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines

    • Hannah P. Priyanka
    • Uday P. Pratap
    • Srinivasan ThyagaRajan

    Original Paper 25 March 2024 Article: 92

    

40. The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinoma

    • Qing-Qing Liu
    • Xiang-Xu Wang
    • Hong-Mei Zhang

    Original Paper 25 March 2024 Article: 91

    

41. Design and evaluation of a multiepitope vaccine for pancreatic cancer using immune-dominant epitopes derived from the signature proteome in expression datasets

    • Sooram Banesh
    • Nupoor Patil
    • Prakash Saudagar

    Original Paper 24 March 2024 Article: 90

    

42. Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells

    • Sneha Krishnamoorthy
    • Rajalakshmi Sabanayagam
    • Sridhar Muthusami

    Original Paper 23 March 2024 Article: 89

    

43. In vitro anticancer activity of Hirudinaria manillensis methanolic extract and its validation using in silico molecular docking approach

    • P. Zeebul Trinita Shannan
    • Susan G. Suganya
    • M. Ramesh

    Original Paper 15 March 2024 Article: 88

    

44. Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer

    • Peipei Wang
    • Yan Pan
    • Xia Wang

    Review Article 12 March 2024 Article: 85

    

45. The cytotoxic effects of prazosin, chlorpromazine, and haloperidol on hepatocellular carcinoma and immortalized non-tumor liver cells

    • Seth Harris
    • Prithvi Nagarajan
    • Kyoungtae Kim

    Original Paper 12 March 2024 Article: 87

    

46. High expression of CD9 and Epidermal Growth Factor Receptor promotes the development of tongue cancer

    • P. C. Suhasini
    • Vadisha Bhat
    • N. Suchetha Kumari

    Original Paper 12 March 2024 Article: 86

    

47. Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator

    • Dipanjan Karati
    • Swarupananda Mukherjee
    • Souvik Roy

    Review Article 05 March 2024 Article: 84

    

48. Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway

    • Aydemir ASDEMİR
    • Aykut ÖZGÜR

    Original Paper 04 March 2024 Article: 83

    

49. An effective treatment approach of liposomally encapsulated metformin in colon cancer

    • Enis Cetin
    • Olcay Boyacioglu
    • Seda Orenay-Boyacioglu

    Original Paper 28 February 2024 Article: 82

    

50. Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against Breast Cancer: In vitro and In silico Analysis

    • Khushi Gupta
    • Pranay Gautre
    • Suresh Thareja

    Original Paper 24 February 2024 Article: 81